Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2010
01/21/2010US20100016311 Novel minor groove binders
01/21/2010US20100016309 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparation Process therefor and Pharmaceutical Composition Containing the Same
01/21/2010US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease
01/21/2010US20100016307 Novel compounds
01/21/2010US20100016303 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
01/21/2010US20100016298 Theramutein modulators
01/21/2010US20100016296 Heteroaryl compounds and uses thereof
01/21/2010US20100016292 Inhibitors of lethal factor protease
01/21/2010US20100016291 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
01/21/2010US20100016289 Compounds Useful as Antagonists of CCR2
01/21/2010US20100016279 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
01/21/2010US20100016278 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
01/21/2010US20100016274 Beta-lactam cannabinoid receptor modulators
01/21/2010US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
01/21/2010US20100016252 Mannich Base N-Oxide Drugs
01/21/2010US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them
01/21/2010US20100015054 Fluoro-substituted benzoxazole polymethine dyes
01/21/2010CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists
01/21/2010CA2731130A1 Pyridazine derivatives as smo inhibitors
01/21/2010CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators
01/21/2010CA2730793A1 Azole compound
01/21/2010CA2730397A1 Substituted indolyl and indazolyl derivatives and uses thereof
01/21/2010CA2730390A1 Aminotetrahydroindazoloacetic acids
01/21/2010CA2728228A1 Oxindolyl inhibitor compounds
01/21/2010CA2728097A1 Methods of preparing imidazole-based bicyclic compounds
01/21/2010CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
01/20/2010EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
01/20/2010EP2144904A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
01/20/2010EP2144903A1 Substituted deuterium enriched thiophenes for the treatment of hypertension
01/20/2010EP2144902A1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
01/20/2010EP2144898A2 Heterocyclic hydrazide compound and pesticidal use of the same
01/20/2010EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors
01/20/2010EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
01/20/2010EP2144503A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
01/20/2010EP1663211B1 Aminotriazole compounds useful as inhibitors of protein kinases
01/20/2010EP1654247B1 Alkynyl aryl carboxamides
01/20/2010EP1633730B1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
01/20/2010CN101628888A Inhibitors of cytosolic phospholipase A2
01/20/2010CN100582104C Oxadiazolone derivatives as PPAR delta agonists
01/20/2010CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
01/20/2010CN100582091C Bis-aryl sulfonamides
01/19/2010US7649096 crystallization of linezolid antibacterial agent in solvent and antisolvent
01/19/2010US7649004 Pyridine derivatives
01/19/2010US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
01/19/2010US7648959 Methods and compositions for the treatment of diseases of the eye
01/19/2010US7648945 cyclic dioxazine substituted pyridyl sulfonylurea derivatives for the selective control of unwanted vegetation in leguminous plants or for the non-selective control of unwanted vegetation
01/19/2010CA2402751C Decahydro-isoquinolines
01/19/2010CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors
01/19/2010CA2239904C Inhibitors of interleukin-1.beta. converting enzyme
01/14/2010WO2010006119A1 Synthesis of metabolically stable agents for alcohol and drug abuse
01/14/2010WO2010005841A1 Inhibitors of janus kinases
01/14/2010WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
01/14/2010WO2010005782A1 Sulfone compounds which modulate the cb2 receptor
01/14/2010WO2010005692A2 Insecticidal cyclic carbonyl amidines
01/14/2010WO2010005572A2 Alpha-keto heterocycles as faah inhibitors
01/14/2010WO2010004972A1 Nitrogen-containing aromatic heterocyclyl compound
01/14/2010WO2010004761A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
01/14/2010WO2010004348A1 Heterocyclic gpcr agonists
01/14/2010WO2010004347A1 Heterocyclic gpcr agonists
01/14/2010WO2010004346A1 Piperidinyl gpcr agonists
01/14/2010WO2010004345A1 Piperidinyl gpcr agonists
01/14/2010WO2010004344A1 Piperidine gpcr agonists
01/14/2010WO2010004228A2 Novel discriminating molecule family for neutron and gamma radiation
01/14/2010WO2010003197A1 Morpholine derivatives used as antifungal compounds
01/14/2010WO2009137251A3 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
01/14/2010WO2009132453A8 Cyclylamine derivatives as calcium channel blockers
01/14/2010WO2009121872A3 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/14/2010WO2009116729A4 Method for refining of high purity of tacrolimus
01/14/2010US20100010045 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
01/14/2010US20100010044 Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide
01/14/2010US20100010035 Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors
01/14/2010US20100010023 Quinazoline derivatives and pharmaceutical compositions containing them
01/14/2010US20100010007 Piperidine derivatives as modulators of chemokine receptor ccr5
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100010003 Pyrimidine Derivatives And Their Use As Pesticides
01/14/2010US20100010001 Novel modulators of sphingosine phosphate receptors
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100009987 Aminothiazole derivatives as inhibitors of mark
01/14/2010US20100009986 Substituted heteroaryl derivatives
01/14/2010US20100009978 Benzoxazoles and Oxazolopyridines Being Useful as Janus Kinases Inhibitors
01/14/2010US20100009975 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
01/14/2010US20100009973 Integrase Inhibitors 3
01/14/2010US20100009971 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound
01/14/2010US20100009968 11beta-hydroxysteroid dehydrogenase type 1 active compounds
01/14/2010US20100009964 Compounds Which Modulate The CB2 Receptor
01/14/2010US20100009962 Benzyl-substituted quinolone m1 receptor positive allosteric modulators
01/14/2010US20100009961 Dipeptidyl peptidase-iv inhibitors
01/14/2010US20100009958 Quinazoline derivatives
01/14/2010US20100009956 Novel substituted pyrimidines as cysteine protease inhibitors
01/14/2010CA2730253A1 Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide
01/14/2010CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
01/14/2010CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound
01/14/2010CA2730037A1 Sulfone compounds which modulate the cb2 receptor
01/14/2010CA2730010A1 Inhibitors of janus kinases
01/14/2010CA2729988A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
01/13/2010EP2143723A1 Salt of heterocycle-substituted pyridine derivative or crystal thereof
01/13/2010EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same
01/13/2010EP2142516A1 Pyrimidine hydrazide compounds as pgds inhibitors
01/13/2010EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2141994A1 Multi-ring compounds and uses thereof